Release date: 2025-06-06 10:13:01 Article From: Lucius Laos Recommended: 9
Understanding the correct way to use abuxitinib is critical to the effectiveness of treatment.
Abuxitinib is indicated for adult patients with specific skin problems.
The recommended starting dose is 100 mg per day, which can be adjusted to 200 mg according to the doctor's recommendation. Patients weighing less than 40 kg should reduce the dose to 50 mg.
It is recommended to take it orally at a fixed time every day, either before or after a meal. Tablets should be swallowed whole, avoiding breaking or chewing. If one dose is missed, the drug should be taken normally at the next dose and no follow-up dose is required.
Routine blood tests and liver function should be monitored regularly during the treatment period. If you have a persistent fever or unusual fatigue, you should seek medical attention. Avoid concomitant use with strong immunosuppressants, which may increase the risk of infection.
Reasonable planning of drug costs can reduce the financial burden of patients.
The price of 30 tablets (100mg/tablet) in the international market is about 1800-2200 US dollars. In some countries, the health insurance system can cover 50%-70% of the cost, and local policies need to be consulted in advance.
Medicines should be stored in a dry environment below 25°C, away from direct sunlight. If it is not used up within 6 months after opening, it should be discarded and cannot be used again.
The average annual cost of treatment for abuxitinib is approximately 40% higher than that of conventional therapy, but clinical data show faster symptom relief and less adjunctive drug use.
The correct use of aboxitinib requires both medical and economic considerations, and patients should maintain close communication with their care team to develop an individualized treatment plan.
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:2562024-09-07
On November 14, 2024, the Committee for Medicinal Products for Human Use (CHMP) of the European Medi···【more】
Recommended:2432025-13-01
Recent advancements have reaffirmed the significance of liquid biopsy in the management of advanced ···【more】
Recommended:2192025-06-01
FDA Approves First Generic Version of Victoza (liraglutide injection)The U.S. Food and Drug Administ···【more】
Recommended:2452024-30-12
The new indication involves the treatment of adult patients with locally advanced, unresectable non-···【more】
Recommended:1992024-24-12
he U.S. Food and Drug Administration (FDA) has approved Crenessity (crinecerfont) for use in combina···【more】
Recommended:2032024-17-12
In the phase Ib/II multicenter pivotal FELIX study, the autologous 41BB-ζ anti-CD19 chimeric antigen···【more】
Recommended:1372024-13-12
On 25 July 2024, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHM···【more】
Recommended:3052024-26-08
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: